PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Global nuclear medicine equipment market • Global SPECT market • Global PET market • Global radiopharmaceuticals market PART 07: Market segmentation by application • Oncology • Cardiology • Neurology PART 08: Market segmentation by end-user • Diagnostic centers • Hospitals • Research centers PART 09: Geographical segmentation • Global nuclear medicine market in Americas • Reimbursement of radiopharmaceuticals in US • Global nuclear medicine market in EMEA • Global nuclear medicine market in APAC PART 10: Market drivers • High demand for SPECT and PET imaging • Rising incidence of cancer and CVDs • Growing demand for radiopharmaceuticals PART 11: Impact of drivers PART 12: Market challenges • High cost of nuclear medicine and time constraints owing to its short half-life • Shortage of nuclear medicine • Regulatory hurdles PART 13: Impact of drivers and challenges PART 14: Market trends • Partnerships for development of nuclear medicine • Production based on cyclotron • Growing funding for R&D PART 15: Vendor landscape • Competitive scenario PART 16: Key vendors • Cardinal Health • Digirad • GE Healthcare • Lantheus Medical Imaging • Philips Healthcare • Other prominent vendors PART 17: Appendix • List of abbreviations PART 18: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Radioisotopes used in medical imaging Exhibit 03: Global nuclear medicine market 2015-2020 ($ billions) Exhibit 04: Five forces analysis Exhibit 05: Global nuclear medicine market segmentation by product Exhibit 06: Global nuclear medicine market segmentation by product 2015 Exhibit 07: Global nuclear medicine market segmentation by product 2020 Exhibit 08: Global nuclear medicine equipment market 2015-2020 ($ billions) Exhibit 09: Global SPECT market 2015-2020 ($ billions) Exhibit 10: Global PET market 2015-2020 ($ millions) Exhibit 11: Global radiopharmaceuticals market 2015-2020 ($ billions) Exhibit 12: Global nuclear medicine market segmentation by application 2015 Exhibit 13: Global nuclear medicine market segmentation by end-user 2015 Exhibit 14: Global nuclear medicine market segmentation by geography 2015 Exhibit 15: Global nuclear medicine market segmentation by geography 2020 Exhibit 16: Global nuclear medicine market segmentation by geography 2015-2020 Exhibit 17: Global nuclear medicine market segmentation by geography 2015-2020 ($ billions) Exhibit 18: Conditions diagnosed using nuclear medicine (in the US) Exhibit 19: Nuclear medicine market in Americas 2015-2020 ($ billions) Exhibit 20: Components for Medicare reimbursement Exhibit 21: Difference in Medicare based on hospital facility and physician's offices Exhibit 22: Reimbursement provided by Medicare for various nuclear medicines 2015 Exhibit 23: Nuclear medicine market in EMEA 2015-2020 ($ billions) Exhibit 24: Nuclear medicine market in APAC 2015-2020 ($ millions) Exhibit 25: Impact of drivers Exhibit 26: Impact of drivers and challenges Exhibit 27: Cardinal Health: Product portfolio Exhibit 28: Cardinal Health: Key takeaways Exhibit 29: Digirad: Business segmentation by revenue 2015 Exhibit 30: Digirad: Business segmentation by revenue 2014 and 2015 ($ millions) Exhibit 31: Digirad: Key takeaways Exhibit 32: GE Healthcare: Product portfolio Exhibit 33: GE Healthcare: Key takeaways Exhibit 34: Lantheus Medical Imaging: Product portfolio Exhibit 35: Regulatory product approvals Exhibit 36: Lantheus Medical Imaging: Product segmentation by revenue 2015 Exhibit 37: Lantheus Medical Imaging: Product segmentation by revenue 2014 and 2015 ($ millions) Exhibit 38: Lantheus Medical Imaging: Key takeaways Exhibit 39: Philips Healthcare: Product portfolio Exhibit 40: Philips Healthcare: Key takeaways Exhibit 41: Other prominent vendors

Cardinal Health, Digirad, GE Healthcare, Lantheus Medical Imaging, Philips Healthcare, ABT Molecular Imaging, Advanced Accelerator Applications, AGFA Healthcare, Algeta, Astellas Pharma, Bayer, Bracco Imaging, Brain Biosciences, Capintec, CMR Naviscan, Cubresa, Eczacibasi-Monrol Nuclear Products, FUJIFILM Holdings, IBA Molecular Imaging, ISOLOGIC Innovative Radiopharmaceuticals, Jubilant DraxImage, Mallinckrodt, Mediso Medical Imaging System, Mirada Medical, Navidea Biopharmaceuticals, Nordion, Piramal Imaging, Positron Pharmaceutical Company, RadioMedix, SHINE Medical Technologies, Sophie Biosciences, Toshiba Medical Systems, Triad Isotopes, Voxel.